Modern sequencing and multi‑omics datasets carry biological sensitivities, wet‑lab variability, individual biological variation, and high‑dimensional complexity. IBA transforms these inputs into clear, biologically meaningful representations using computational genomics, statistical rigor, and AI‑based modeling. We extract robust molecular signals, integrate multi‑omics and time‑series evidence, and generate experiment‑ready gene sets and biomarker panels that refine pathways and strengthen biological interpretation for research and diagnostics.
Clinical and biomedical datasets often involve small cohorts, uneven measurements, missing modalities, and multimodal complexity. IBA structures these challenging inputs using clinical bioinformatics, statistical rigor, and AI-based modeling to create reliable, interpretable representations. We identify meaningful biomarkers, integrate multimodal and longitudinal evidence, and apply mechanism-focused AI analysis to reveal precise therapeutic opportunities and support clinical decision-making.
We build reproducible, transparent analytical pipelines that preserve scientific intent from raw data to interpretable output. Each stage is designed for rigor, traceability, and long‑term adaptability, enabling reliable collaboration and future refinement.
IBA provides scientific partnership for questions that fall outside standard analytical paths. We translate uncertainty into a clear analytical direction and a practical next step, ensuring the right question is defined before resources are committed.
